Dr Reddy's Q4 net profit rises by 319%
GV Prasad, Co-Chairman and CEO of Dr Reddy's Laboratories said, “FY17 has been challenging year due to lack of new product approvals for the US market. However, our other geoghraphies delivered good performance with several new product launches.”
A Bloomberg poll estimated Dr Reddy's net profit to be at Rs 418 crore this Q4. Photo: Pixabay